Formato
PDF
Isquemia miocardica/etiología; factores de riesgo
Achiong EF, Achiong AF, Hernández CE, Morales RJ, Cabeza S. Prevalencia
de factores de riesgo de enfermedades transmisibles en el Policlínico
" Milanés", Municipio de Matanzas. Rev Médica Matanzas
(Revista electrónica) 1998 (citado 27 feb 2001); 20 (3): (13 pantallas).
Disponible en URL: http://WWW. mtz.sld.cu/RME03398.htm
Álvarez Sala LA, Valderraman M, Porres A, Gómez Gerique JA, rodríguez Gorostiza FJ, Torre SFJ, et al. Alcohol y enfermedad cardiovascular. Cardiov Risk Factor (Revista electrónica) 2000 (citado 29 mar 2001): 9(6): (27 pantallas). Disponible en URL: http:// crf. medynet. com/contenido/2000/5/328-41.pdf
Austin MA. Epidemiology of hipertriglyceridemia and cardiovascular disease. Am J Cardiol 1999; 83 (98): 13F-16F.
Bili A, Moss AJ Francis CW, Zareba W, Watelet LF, Sanz L. Related Articles Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators. Circulation (Online) 2000; 102(11): 1258-63.
Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999; 149(2):151-61.
Chalmers J. Cardiovascular disease. WHO-ISE hypertension. Commiters. Ginebra: World Health Organization, 1999. Disponible en URL: http://www.who.int/ncd/cvd/ht-guide.html#c212
Denollet J, Vaes J, Brutsaert DL. Related Articles Inadequate response to treatment in coronary heart disease: adverse effects of type D personality and younger age on 5-year prognosis and quality of life. Circulation 2000;102(6):630-5.
Edmunds E, Landray M, Lip Gy. Related Articles Association between elevated plasma a fibrinogen and the small, dense low-density lipoprotein phenotype among postmenopausal women. Am J cardiol 2000;86(1):126.
Fauchier L, Maison BP, Forhan A, D'Hour A, Lepinay P, Tichet J, et al. Related Articles Association between heart rate-corrected QT interval and coronary risk factors in 2,894 healthy subjects (the DESIR Study). Data from an Epidemiological study on the Insulin Resistance syndrome. Am J Cardiol 2000;86(5):557-9,A9.
Ferrario CM, Deitch JS, Dean RH, Strawn WB. Hipertensión y arterosclerosis: una interpretación mecánica de la progresión de la enfermedad/Editorial/. Cardiovasc Risk Factor 1997;6(3):139-50.
García MX, Caski JC. Cardiopatía isquémica: marcadores de inflamación y riesgo cardiovascular. Rev Cubana Med (Revista electrónica) 2000 (citado 13 mar 2000); 39(2):120-40 (50 pantallas). Disponible en URL:http://www.sld.cu/revistas/med/vol139 _ 2 _ 00/med07200.htm#*
Germin A, Machraqui A, Braun BE, Barmeyer J. Apolipoproteína B como factor de riego para la asterosclerosis coronaria. Cardiovasc Risk Factor 1998;7(6):335-8.
Grech ED, Sutton AG, Campbell PG, Ashton VJ, Price DJ, All JA, et al. Related Articles Reappraising the role of immediate intervention following trombolytic recanalization in acute myocardial infarction. Am J Cardiol 2000;86(4);400-5.
La hipertensión arterial como factor de riesgo cardiovascular. Sístole 2000;228:14-5.
La hipertensión arterial, sobre todo la asociada al ventrículo izquierdo, es el principal factor de riesgo en España a la hora de sufrir un infarto y no el incremento de la tasa de colesterol. Sístole 2000;228:17.
Holmwang L, Andersen K, Dellberg N, Clemmensen P, Wagner S, Grande P, et al. Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease. Am J Cardiol 1999;83(5):667-74.
Hujoel PP, Drangsholt M, Spiekerman C, De Rouen TA. Related Articles Periodontal disease and coronary heart disease risk. Jama 2000;284(11):1406-10.
Jacobson TA. Related Articles. " The lower the better" in hypercholesterolemia therapy: a reliable clinical guideline? Ann Intern Med 2000;133(7):549-54. Review.
Kaski JC, García MX. Related Articles. C-reactive protein as a clinical marker of risk. Circulation (Online) 2000;102(9):E63-4.
Kontos MC, Jesse RL, Anderson FP, Schmidt KL, Ornato JP, Tatum JL. Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain. Circulation 1999;99(16):2073-8.
Kunst AE, Groenhof F, Andersen O, Borgan JK, Costa G, Desplanques G, et al. Occupational class and ischemic heart disease mortality in the United States and 11 European countries. Am J Public Health 1999;89(1);47-53.
López GAV, García RJC. Tabaco y enfermedad coronaria Risk factor. Cardiovasc Risk Factor (Revista electrónica) 2000 (citado 29 mar 2001);9(6): (9 pantallas). Disponible en URL: http://crf.medynet. com/contenido/2000/6/408-416.pdf
Di Mascio R, Marchioli R, Marfisi RM, Kramer V, Vitullo F, Tognono G. ¿ Son comunes los factores de riesgo aterogénicos relacionados de forma diferente con el accidente cerebrovascular isquémico y el infarto del miocardio? Cardiovasc Risk Factor 1998;7(6):324-33.
Malarcher Am, Schulman J, Epstein LA, Thun MJ, Mowery P, Pierce B, et al. Related Articles. Methodological issues in estimating smoking-attributable mortality in the United states. Am J Epidemiol 2000;152(6):573-84.
Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the Oasis (Organization to Assess Strategies for Ischemic syndromes) Registry. Circulation (Online) 2000;102(9):1014-9.
Mehilli J, Kastrati A, Dirschinger J, Bollwein H, Neumann FJ, Schomig A.
Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA 2000;284(14):1799-805.
Moreno MP, Reyes BPS, Rondon ME, Rodríguez LA. Cardiopatía isquémica. Factores de riesgo coronario. Arch Med Camagüey (Revista electrónica) 2000;4(3): (16 pantallas). Disponible en URL: http://www.cmw.sld.cu/amc/v4n3/346.htm
Mormando RM. Related Articles. Lipid levels. Applying the second national Cholesterol Education Program report to geriatric medicine. Geriatrics 2000;55(8):48-53.
Pasquet A, Robert A, D'Hondt AM, Dion AM, Melin JA, Vanoverschelde JL. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 1999; 100(2):141-8.
Polanczyk CA, Johnson PA, Cook EF, Lee TH. A proposed strategy for utilization of creatine kinase-MB and troponin I in the evaluation of acute chest pain. Am J Cardiol 1999;83(8):1175-9.
Prohías MJ, Padrón AS, Basán MM, Ramos EC, Castro AA, Anello UH. Efectos agudos de fumar cigarrillo sobre la función diastólica en pacientes con cardiopatía isquémica. Rev Cubana Cardiol Cir Cardiovasc (Revista electrónica) 1999 (citado 14 mar 2000); 13(2):91-7 (17 pantallas). Disponible en URL: http://www.sld.cu/revistas/car/vol113_2_99/car02299.htm # *
Reilly B, Durairaj L, Husain s, Acob C, Evans A, Hu TC. Performance and potential impact of a chest pain prediction rule in a large public hospital (see comments). Am J Med 1999; 106(3):285-91.
Rivenes SM, Kearney DL, Smith EO, Towbin JA, Denfield SW. Related Articles. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 2000;102(8):876-82.
Sol SJ del, Pila PR, Martínez A, Colunga SJ, Guerra RC. Relación entre la hipertensión arterial y la cardiopatía esquémica. Arch Med Camagüey (Revista electrónica) 2000;4(1): (15 pantallas). Disponible en URL: http://www.cmw.sld.cu/am c/v4n1/271.htm
Stomel R, Grant R, Eagle KA. Lessons learned from a community hospital chest pain center. Am J Cardiol 1999;83(7):1033-7.
Stubbs PJ, AL-Obaidi MK, Conroy RM, MusB, Collinson PQ, MRCPath, et al. Related Articles. Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes. Circulation 2000;102(6):605-10.
Tommasi S, Carluccio E, Bentivoglio M, Buccolieri M, Mariotti M, Politano M, et al. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol 1999;83(12):1595-9.
Wittrup HH, Tybjaerg HA, Nordestgaard BG. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A metaanalysis. Circulation 1999;99(22):2901-7.
Isquemia miocardica/prevención y control
Altman DG. Randomisation in the symphony trial. Lancet 2000;356(9240):1521-2.
Avellaneda E. Estudio de prevención secundaria de la crdiopatía isquémica en la atención primaria (Presenciap). Atención primaria (Revista electrónica) 2001 (citado 14 mar 2001); 27(1):29-32 (16 pantallas). Disponible en URL: http:// db. doyma.es/cgibin/wdbcgi.exe/doyma/mrevista.fulltext
Beth DL, Ernst ND. Choose a Diet That is low in Saturated Fat and cholesterol and moderate in total fat: subtle changes to familiar message J. Nutrition (Revista electrónica)2001 (citado 19 mar 2001); 131:510S-526S (61 pantallas). Disponible en URL:http://www. nutrition.org/cgi/content/full/131/1/
Bhargava B, Minthn GS, Mehran R, Lansky AJ, Weissman NJ, Walsh C, et al. Related Articles. Serial volumetric intravascular ultrasound analysis of the efficacy of beta irradiation in preventing recurrent in-stent restenosis. Am J Cardiol 2000;85(5):651-3,A10.
Boden WE, Pearson TA. Related Articles. Raising low levels of high-density lipoprotein cholesterol is an important target of therapy. Am J Cardiol 2000;85(5):645-50,A10.
Burr ML, Lessons from the story of n-3 fatty acids. Am J Clin Nutr 2000; 71(1 Suppl):397S-8S.
Cohen DJ, Carroza JP, Baim DS, Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease (letter comment) Comentario: Comment on:/N Engl J Med/1999 jul 8;341(2):70-6. N Engl J Med 1999; 341(24):1853-4;discussion 1845-5.
Inagaki K, Kihara Y, Hayashida W, Izumi T, Iwanaga Y, Yoneda T, et al. Anti-ischemic effect of a novel cardioprotective agent, JTV519, is mediated through specific activation of delta-insoform of protein kinase C in rat ventricular myocardium. Circulation 2000;101(7):797-804.
Miniati DN, Hoyt EG, Feeley BT, Poston RS, Robbins RC. En vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 kinase inhibit graft coronary artery disease. Circulation 2000;102(19 Suppl 3):III237-42.
Naghavi M, Barlas S, Siadaty S, Nagwib S, Hadjid M, Casscells W. Related Articles. Association on influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102(25):3039-45.
Nelson JC, kennedy JS, Pollock BG, Laghrissi TF, Narayan M, Nobler MS, et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart heart disease. Am J Psychiatry 1999;156(7):1024-8.
Saez T, Suarez C, Blando F, Gabriel R, Epidemiology of cardiovascular diseases in the Spanish elderly population. Rev Esp cardiol 1998;51(11):864-73.
Serrano APJ, Casasnovas LJA, Ferreira MIJ. Impacto de las distintas estrategias en prevención cardiovascular. Cardiov Risk Factor (Revista electrónica) 2000 (citado 29 mar 2001); 9(4): (23 pantallas). Disponible en URL: http://crf.medynet.com/contenido/2000/4/250-257.pdf
Smith SCJr, Greenland P, Grundy SM. AHA Conference Proceedings. Prevention conference V. Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart association. Circulation 2000;101(1):111-6.
SoRelle R. Cardiovascular news. INHIBIT. Circulation 2000;102(25):E9050-1.
Toyoda Y, Di Gregorio V, Parker RA, Levitsky S, Mc Cully JD. Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning. Circulation 2000;102(19 Suppl 3):III326-31.
Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 2000;102(25):313-47.
Verstraete M. Synthetic inhibitors of platelet glycoprotein IIb/IIIa in clinical development. Circulation 2000;101(6):E76-80.
Waugh RJ. Dietary fiober and weight gain (letter). JAMA 2000;283(14):1821; discussion 1821-2.
Isquemia Miocardica/epidemiología
Batista MR, Landrove RO, Bonet GM, Feal CP, Ramírez M. Sistema de vigilancia de enfermedades no trasmisibles en cuba. Rev Cubana Hig Epidemiol (Revista electrónica) 2000 (citado 20 mar 2001);38(2):77-92. Disponible en URL: http://www.sld.cu/revistas/hie/vol38_2_00/hie01200.htm
Cooper R, Cutler J, Desvigne NP, Fortmann SP, Friedman L, Havlik R, et al.
Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 2000;102(25):3137-47.
Guerre BP, Crama P, Prima F, Oddoze C, Branchereau A, Gouin F, et al. Incidence of myocardial lesions after vascular surgery: diagnosis by troponin Ic. Ann Fr Anesth Reanim 1997;16(8):950-4.
Herings RM, Leufkens HG, Vandenbroucke JP. Acute myocardial infarction and prior antibiotic use. JAMA 2000;284(23):2998-9.
López SJ, López SE de, Rubio R, Delcan JL. Microorganism in vascular pathology and myocardial ischemia. Rev Clin Esp 1998;(198 Suppl 1):40-3.
Lotufo PA, Chae CU, Ajani UA, Hennekens CH, Manson JE. Male pattern baldness and coronary heart disease: the Physicians' Health Study. Arch Intern Med 2000;160(2):165-71.
Nelson JC, Kennedy JS, Pollock BG, Laghrissi TF, Narayan M, Nobler MS, et al. Treatmen of major depression wit nortriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry 1999;156(7):1024-8.
Novella AB, Gabriel R. Prevalencia e incidencia de cardiopatía isquémica, IAM y angina. Cardiov Risk Factor (Revista electrónica) 2000 (citado 29 mar 2001); 9(4): (13 pantallas). Disponible en URL: http://crf.medynet.com/contenido/2000/4/258-262.pdf
Orth GK,Wamala SP, Horsten M, Schenck GK, Schneiderman N, Mittleman MA.
Marital stress worsens prognosis in women with coronary heart disease: The Stockholm y emale Coronary Risk Study. JAMA 2000;284(23):3008-14.
Rice GI, Grant PJ. FVIII coagulant activity and antigen in subjects with ischaemic heart disease. Thromb Haemost 1998;80(5):757-62.
Saez T, Suarez C, Blanco F, Gabriel R. Epidemiology of cardiovascular diseases in the Spanish elderly population. Rev Esp Cardiol 1998;51(11):864-73.
Sakurai A, Oka S, Sekine J, Tanaka H, Nagasawa Y, Numao Y, et al. Changes of ischemic heart disease in Utsunomiya, Japan, over 10 years: a survery of primary care physicians. Jpn Circ J 1998;62(9):675-9.
Theroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, Schroeder JS, et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in hight-risk ischemic situation. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) investigators. Circulation 2000;102(25):3032-8.
Thiemann DR, Coresh J, Powe NR. Quality of care at teaching and nonteaching hospitals. JAMA 2000;284(23):2994-5.
Walker AR, Walker BF. Iron and ischemic heart disease in the African setting (letter). Arch Intern Med 2000;160(2):241-2.
Estimado usuario:
Usted puede hallar información sobre Cardiopatía Isquémica en los siguientes sitios Web.
Myocardial Ischemia http://www. cs. columbia.edu/
Myocardial Ischemia. General Considerations
http://www.acc.org/clinical/guidelines/ae/ae/8a.htm
Echocardiography Guidelines Executive Summary: Ischemic Heart Diseae http://www.acc.org/clinical/guidelines/echol/ec4.htm
" La recuperación cardíaca a través de la rehabilitación"
http:/hstat.nlm.nih.gov/
Descriptores empleados para la recuperación de información en las bases de Datos CUMED, LILACS Y MEDLINE en ingles y en español, tomado del tesauro DeCS y MeSH donde se encuentran los términos autorizados por el sistema de información de Salud para una búsqueda con precisión.
Descriptores DeCs- Mesh
ISQUEMIA MIOCÁRDICA/epidemiología MYOCARDIAL ISCHEMIA/epidemiology ISQUEMIA MIOCÁRDICA/Etiología MYOCARDIAL ISCHEMIA/etiología FACTORES DE RIESGO RISK FACTOR Isquemia Miocárdica/Prevención y control MYOCARDIAL ISCHEMIA/Prevention and control